• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

SYBR Green I 疟原虫药物敏感性检测法：在低疟原虫血症样本中的性能。

The SYBR Green I malaria drug sensitivity assay: performance in low parasitemia samples.

机构信息

Institute of Specific Prophylaxis and Tropical Medicine, Medical University of Vienna, Kinderspitalgasse 15, A-1090 Vienna, Austria.

出版信息

Am J Trop Med Hyg. 2010 Mar;82(3):398-401. doi: 10.4269/ajtmh.2010.09-0417.

DOI:10.4269/ajtmh.2010.09-0417
PMID:20207863
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2829899/
Abstract

Validation of the sensitivity of the SYBR Green I in vitro test against an enzyme-linked immunosorbent assay (ELISA)-based drug sensitivity assay. Our results suggest that the SYBR Green I assay is a fast and inexpensive malaria drug screening assay for laboratory use. However, because of its lack of sensitivity in whole blood samples its usefulness for testing clinical samples may be limited.

摘要

验证 SYBR Green I 体外试验对基于酶联免疫吸附测定 (ELISA) 的药物敏感性测定的敏感性。我们的结果表明，SYBR Green I 测定法是一种快速且廉价的实验室用疟疾药物筛选测定法。然而，由于其在全血样本中的灵敏度不足，因此其用于测试临床样本的用途可能受到限制。

相似文献

1
The SYBR Green I malaria drug sensitivity assay: performance in low parasitemia samples.SYBR Green I 疟原虫药物敏感性检测法：在低疟原虫血症样本中的性能。
Am J Trop Med Hyg. 2010 Mar;82(3):398-401. doi: 10.4269/ajtmh.2010.09-0417.
2
Comparison of a SYBR green I-based assay with a histidine-rich protein II enzyme-linked immunosorbent assay for in vitro antimalarial drug efficacy testing and application to clinical isolates.基于SYBR Green I的检测方法与富含组氨酸蛋白II酶联免疫吸附测定法用于体外抗疟药物疗效测试及在临床分离株中的应用比较。
Antimicrob Agents Chemother. 2007 Apr;51(4):1172-8. doi: 10.1128/AAC.01313-06. Epub 2007 Jan 12.
3
Performance and reliability of the SYBR Green I based assay for the routine monitoring of susceptibility of Plasmodium falciparum clinical isolates.基于SYBR Green I的检测方法用于恶性疟原虫临床分离株药敏常规监测的性能与可靠性
Trans R Soc Trop Med Hyg. 2008 Apr;102(4):346-51. doi: 10.1016/j.trstmh.2008.01.021. Epub 2008 Mar 5.
4
Assessment of the drug susceptibility of Plasmodium falciparum clinical isolates from africa by using a Plasmodium lactate dehydrogenase immunodetection assay and an inhibitory maximum effect model for precise measurement of the 50-percent inhibitory concentration.通过使用乳酸脱氢酶疟原虫免疫检测法和抑制最大效应模型精确测量50%抑制浓度，评估来自非洲的恶性疟原虫临床分离株的药物敏感性。
Antimicrob Agents Chemother. 2006 Oct;50(10):3343-9. doi: 10.1128/AAC.00367-06.
5
Simple histidine-rich protein 2 double-site sandwich enzyme-linked immunosorbent assay for use in malaria drug sensitivity testing.用于疟疾药物敏感性检测的简易富组氨酸蛋白2双位点夹心酶联免疫吸附测定法。
Antimicrob Agents Chemother. 2005 Aug;49(8):3575-7. doi: 10.1128/AAC.49.8.3575-3577.2005.
6
Malaria drug-susceptibility testing. HRP2-based assays: current data, future perspectives.疟疾药物敏感性检测。基于HRP2的检测方法：当前数据与未来展望。
Wien Klin Wochenschr. 2003;115 Suppl 3:23-7.
7
Direct comparison of the histidine-rich protein-2 enzyme-linked immunosorbent assay (HRP-2 ELISA) and malaria SYBR green I fluorescence (MSF) drug sensitivity tests in Plasmodium falciparum reference clones and fresh ex vivo field isolates from Cambodia.直接比较富组氨酸蛋白-2 酶联免疫吸附测定（HRP-2 ELISA）和疟疾 SYBR 绿 I 荧光（MSF）药敏试验在恶性疟原虫参考克隆和柬埔寨新鲜的现场分离株中的应用。
Malar J. 2013 Jul 12;12:239. doi: 10.1186/1475-2875-12-239.
8
Assessment of the Worldwide Antimalarial Resistance Network Standardized Procedure for In Vitro Malaria Drug Sensitivity Testing Using SYBR Green Assay for Field Samples with Various Initial Parasitemia Levels.使用SYBR Green分析法对具有不同初始寄生虫血症水平的现场样本进行体外疟疾药物敏感性测试的全球抗疟药物耐药性网络标准化程序的评估。
Antimicrob Agents Chemother. 2016 Mar 25;60(4):2417-24. doi: 10.1128/AAC.00527-15. Print 2016 Apr.
9
[Evaluation of in vitro drug sensitivity of antimalarials for Plasmodium falciparum using a colorimetric assay (DELI-microtest)].[使用比色法（DELI-微测试）评估抗疟药对恶性疟原虫的体外药物敏感性]
Med Trop (Mars). 2001;61(6):545-7.
10
Assessment and continued validation of the malaria SYBR green I-based fluorescence assay for use in malaria drug screening.用于疟疾药物筛选的基于SYBR Green I的疟疾荧光检测方法的评估及持续验证。
Antimicrob Agents Chemother. 2007 Jun;51(6):1926-33. doi: 10.1128/AAC.01607-06. Epub 2007 Mar 19.

引用本文的文献

1
Clinically applicable parasite viability assay for rapid assessment of antimalarial pharmacodynamic endpoints.用于快速评估抗疟药效学终点的临床适用寄生虫活力测定法。
Antimicrob Agents Chemother. 2025 Aug 6;69(8):e0186324. doi: 10.1128/aac.01863-24. Epub 2025 Jun 17.
2
Marine Guanidine Alkaloids Inhibit Malaria Parasites Development in , and Assays.海洋胍生物碱在、和试验中抑制疟原虫发育。
ACS Infect Dis. 2025 Jul 11;11(7):1854-1867. doi: 10.1021/acsinfecdis.4c00714. Epub 2025 Apr 15.
3
Oleuropein activates autophagy to circumvent anti-plasmodial defense.橄榄苦苷激活自噬以规避抗疟防御。
iScience. 2024 Mar 11;27(4):109463. doi: 10.1016/j.isci.2024.109463. eCollection 2024 Apr 19.
4
Anti-malarial activity of the alkaloid, heptaphylline, and the furanocoumarin, imperatorin, from Clausena anisata against human Plasmodium falciparum malaria parasites: ex vivo trophozoitocidal, schizonticidal and gametocytocidal approach.从山黄皮中提取的生物碱七叶亭和呋喃香豆素花椒毒素抗恶性疟原虫的抗疟活性：体外滋养体杀伤、裂殖体杀伤和配子体杀伤方法。
Malar J. 2023 Sep 9;22(1):264. doi: 10.1186/s12936-023-04678-0.
5
Cripowellins Pause Intraerythrocytic Development at the Ring Stage.疟原虫在环状体期的内液泡发育暂停。
Molecules. 2023 Mar 13;28(6):2600. doi: 10.3390/molecules28062600.
6
Rational-Based Discovery of Novel β-Carboline Derivatives as Potential Antimalarials: From In Silico Identification of Novel Targets to Inhibition of Experimental Cerebral Malaria.基于理性设计发现新型β-咔啉衍生物作为潜在抗疟药：从新型靶点的计算机模拟鉴定到对实验性脑型疟疾的抑制
Pathogens. 2022 Dec 13;11(12):1529. doi: 10.3390/pathogens11121529.
7
In vitro and in silico assessment of new beta amino ketones with antiplasmodial activity.新型抗疟β-氨基酮的体外和计算机评估。
Rev Soc Bras Med Trop. 2022 Sep 26;55:e0590. doi: 10.1590/0037-8682-0590-2022. eCollection 2022.
8
Synthesis, Structure−Activity Relationships, and Parasitological Profiling of Brussonol Derivatives as New Plasmodium falciparum Inhibitors.布鲁索醇衍生物作为新型恶性疟原虫抑制剂的合成、构效关系及寄生虫学分析
Pharmaceuticals (Basel). 2022 Jun 30;15(7):814. doi: 10.3390/ph15070814.
9
Selected Derivatives of Erythromycin B- and Anti-Malarial Studies.红霉素B的选定衍生物及抗疟疾研究。
Materials (Basel). 2021 Nov 18;14(22):6980. doi: 10.3390/ma14226980.
10
Antiprotozoal and Antibacterial Activity of Ravenelin, a Xanthone Isolated from the Endophytic Fungus .拉文宁，一种从内生真菌中分离得到的黄烷酮，具有抗原生动物和抗菌活性。
Molecules. 2021 Jun 2;26(11):3339. doi: 10.3390/molecules26113339.

本文引用的文献

1
Performance and reliability of the SYBR Green I based assay for the routine monitoring of susceptibility of Plasmodium falciparum clinical isolates.基于SYBR Green I的检测方法用于恶性疟原虫临床分离株药敏常规监测的性能与可靠性
Trans R Soc Trop Med Hyg. 2008 Apr;102(4):346-51. doi: 10.1016/j.trstmh.2008.01.021. Epub 2008 Mar 5.
2
Comparison of a SYBR green I-based assay with a histidine-rich protein II enzyme-linked immunosorbent assay for in vitro antimalarial drug efficacy testing and application to clinical isolates.基于SYBR Green I的检测方法与富含组氨酸蛋白II酶联免疫吸附测定法用于体外抗疟药物疗效测试及在临床分离株中的应用比较。
Antimicrob Agents Chemother. 2007 Apr;51(4):1172-8. doi: 10.1128/AAC.01313-06. Epub 2007 Jan 12.
3
High-throughput Plasmodium falciparum growth assay for malaria drug discovery.用于疟疾药物发现的高通量恶性疟原虫生长测定法。
Antimicrob Agents Chemother. 2007 Feb;51(2):716-23. doi: 10.1128/AAC.01144-06. Epub 2006 Nov 20.
4
In vitro antimalarial activity of azithromycin, artesunate, and quinine in combination and correlation with clinical outcome.阿奇霉素、青蒿琥酯和奎宁联合使用的体外抗疟活性及其与临床结果的相关性。
Antimicrob Agents Chemother. 2007 Feb;51(2):651-6. doi: 10.1128/AAC.01023-06. Epub 2006 Nov 20.
5
Drug-resistant malaria in Bangui, Central African Republic: an in vitro assessment.中非共和国班吉的耐药疟疾：一项体外评估
Am J Trop Med Hyg. 2005 Aug;73(2):239-43.
6
Simple histidine-rich protein 2 double-site sandwich enzyme-linked immunosorbent assay for use in malaria drug sensitivity testing.用于疟疾药物敏感性检测的简易富组氨酸蛋白2双位点夹心酶联免疫吸附测定法。
Antimicrob Agents Chemother. 2005 Aug;49(8):3575-7. doi: 10.1128/AAC.49.8.3575-3577.2005.
7
Novel, rapid, and inexpensive cell-based quantification of antimalarial drug efficacy.新型、快速且廉价的基于细胞的抗疟药物疗效定量分析。
Antimicrob Agents Chemother. 2004 May;48(5):1807-10. doi: 10.1128/AAC.48.5.1807-1810.2004.
8
Simple and inexpensive fluorescence-based technique for high-throughput antimalarial drug screening.用于高通量抗疟药物筛选的简单且低成本的荧光技术。
Antimicrob Agents Chemother. 2004 May;48(5):1803-6. doi: 10.1128/AAC.48.5.1803-1806.2004.
9
A novel DNA-based microfluorimetric method to evaluate antimalarial drug activity.一种基于DNA的新型微量荧光法用于评估抗疟药物活性。
Am J Trop Med Hyg. 2004 Feb;70(2):119-24.
10
Plasmodium falciparum and Plasmodium vivax: lactate dehydrogenase activity and its application for in vitro drug susceptibility assay.恶性疟原虫和间日疟原虫：乳酸脱氢酶活性及其在体外药物敏感性测定中的应用。
Exp Parasitol. 1995 Mar;80(2):260-71. doi: 10.1006/expr.1995.1032.